Monday, December 30, 2019

Ever wonder why USA is the MOST DRUGGED nation?


 The Answer

Twenty one out of the top Thirty five Pharmaceutical companies are  American.
This is the legal segment 
regarding  illicit or  previously illicit dugs  some other time.



From WIKIPEDIA




Rank[N 1] Company Largest Market Cap (USD billions) Market Cap in 2018 (USD billions) Market Cap in 2017 (USD billions) Market Cap in 2016 (USD billions)[1][2] Market Cap in 2015 (USD billions)[3] Market Cap in 2014 (USD billions)[4] Market Cap in 2013 (USD billions)
1 Steady United States Johnson & Johnson[P]
NYSEJNJ
397.4 (Jan 2018) 346.1 375.4 314.1 284.2 277.8 258.3
2 Steady United States Pfizer[P]
NYSEPFE
310.5 (Jul 2000) 259.7 215.9 196.3 199.3 205.4 196.0
3 Steady Switzerland Roche[P]
SIXROG
263.6 (Feb 2014) 209.3 216.7 192.1 234.7 258.5 240.3
4 Increase2 United States Merck & Co.[P]
NYSEMRK
213.6 (Nov 2018) 205.8 153.3 164.3 147.6 166.9 146.5
5 Decrease1 Switzerland Novartis[P]
NYSENVS
275.2 (Jul 2015) 200.0 196.7 170.5 206.1 229.8 195.0
6 Decrease1 United States AbbVie[P]
NYSEABBV
196.2 (Jan 2018) 146.3 154.4 100.2 96.8 104.1 83.8
7 Steady United States Amgen[B]
NASDAQAMGN
143.0 (Jan 2018) 128.8 126.2 108.9 122.5 93.1 78.7
8 Steady United States Abbott Laboratories[P]
NYSEABT
130.2 (Dec 2018) 126.8 99.3 56.4 67.0 67.9 59.3
9 Increase1 United States Eli Lilly & Co[P]
NYSELLY
131.2 (Feb 2019) 125.6 93.0 80.9 93.4 76.6 57.0
10 Decrease1 Denmark Novo Nordisk[P]
NYSENVO
159.6 (Aug 2015) 111.9 131.2 92.6 153.9 125.4 19.6
11 Steady France Sanofi[P]
NYSESNY
151.3 (Sep 2014) 108.4 108.2 101.8 111.8 138.1 142.0
12 Increase2 United Kingdom AstraZeneca[P]
NYSEAZN
105.1 (Nov 2018) 96.2 87.9 68.8 85.8 88.9 74.6
13 Increase2 United Kingdom GlaxoSmithKline[P]
NYSEGSK
174.9 (May 2006) 94.8 87.9 93.3 97.6 128.9 129.6
14 Decrease1 United States Bristol-Myers Squibb[P]
NASDAQBMY
128.3 (Jul 2016) 85.0 100.3 98.2 114.8 97.6 87.2
15 Decrease2 United States Gilead Sciences[B]
NASDAQGILD
179.6 (Jun 2013) 81.6 93.6 96.6 145.8 109.0 78.4
16 Steady United States Biogen[B]
NASDAQBIIB
111.7 (Mar 2015) 63.5 67.4 61.6 68.3 79.7 66.1
17 Increase3 Germany Bayer[B]
FWBBAYN
129.0 (Mar 2015) 63.1 101.9 85.3 103.2 113.2 117.4
18 Decrease1 United States Stryker Corporation[P]
NYSESYK
67.6 (Feb 2019) 58.6 58.0 45.1 34.7 35.7 28.4
19 Increase2 Republic of Ireland Shire Pharmaceuticals[P]
NASDAQSHPG
62.0 (Sep 2014) 53.0 47.0 50.1 41.0 42.4 28.1
20 Steady Japan Takeda Pharmaceutical [P]
NASDAQTYO
59.6 (June 2007) 52.9 40.2 45.6 47.8 37.5 34.3
21 Decrease2 United States Celgene[B]
NASDAQCELG
115.3 (Oct 2017) 46.6 82.2 91.4 94.1 89.5 69.2
22 Decrease4 Republic of Ireland Allergan[P]
NYSEAGN
133.5 (Jul 2015) 46.2 54.4 72.7 123.3 68.5 29.3
23 Decrease1 United States Illumina [B]
NASDAQILMN
54.0 (Sept 2018) 44.1 40.2 39.4 35.4 28.6 25.7
24 Decrease1 United States Vertex Pharmaceuticals[P]
NASDAQVRTX
49.1 (Sept 2018) 42.2 37.9 18.3 31.0 28.7 17.4
25 Decrease1 United States Zoetis[P]
NASDAQZTS
46.1 (Nov 2018) 41.4 35.1 26.4 23.8 21.6 16.3
26 Decrease1 United States Regeneron Pharmaceuticals[P]
NASDAQREGN
61.4 (Aug 2015) 40.3 40.4 39.3 56.5 42.0 27.4
27 Decrease1 Japan Astellas[P]
TYO: 4503
35.9 (Nov 2017) 23.8 29.3 25.7 40.6 35.8 27.6
28 Increase2 Japan Eisai Pharmaceutical [P]
TYO: 4523
24.7 (June 2018) 23.0 24.5 37.3 28.8 30.2 28.7
29 Steady Japan Daiichi Sankyo [P]
NASDAQDSNKY
27.9 (June 2018) 22.7 27.5 35.3 38.8 33.2 28.7
30 Decrease1 United States Alexion Pharmaceuticals[P]
NASDAQALXN
47.0 (Jul 2015) 21.7 26.7 27.4 43.1 36.7 26.0
31 Decrease1 United States BioMarin [P]
NASDAQBMRN
24.0 (Jul 2015) 15.1 18.3 20.4 13.8 12.9 10.8
32 Decrease1 United States Mylan [P]
NASDAQMYL
37.2 (Apr 2015) 14.1 27.5 30.3 38.8 33.2 35.7
33 Steady United States Incyte [P]
NASDAQINCY
31.2 (Mar 2017) 13.5 18.3 15.4 10.6 7.3 4.6
34 Steady United States Perrigo [P]
NASDAQPRGO
29.0 (May 2017) 5.5 9.9 9.5 8.3 14.7 12.2
35 Steady United States United Therapeutics [P]
Template:UTHR
6.0 (May 2018) 5.5 8.9 7.5 8.3 11.7 7.2

No comments: